Notice of Effectiveness (effect)
2022年8月23日 - 7:03PM
Edgar (US Regulatory)
|
UNITED STATES
|
|---|
|
SECURITIES AND EXCHANGE COMMISSION
|
|---|
|
Washington, D.C. 20549
|
|---|
NOTICE OF EFFECTIVENESS |
|---|
|
| Effective Date: | August 22,
2022 |
|---|
| Accession Number: | 0001140361-22-029967 |
|---|
| Submission Type: | POS AM |
|---|
| CIK: | 0001595893 |
|---|
| Company Name: | Turning Point Therapeutics, Inc. |
|---|
| File Number: | 333-238300 |
|---|
Turning Point Therapeutics (NASDAQ:TPTX)
過去 株価チャート
から 5 2024 まで 6 2024
Turning Point Therapeutics (NASDAQ:TPTX)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Turning Point Therapeutics Inc (ナスダック市場): 0 recent articles
その他のTurning Point Therapeutics, Inc.ニュース記事